J&J Reaches $40.5M Opioid Deal With NH, Avoiding Trial
Johnson & Johnson and its subsidiary Janssen announced Thursday that they have reached a $40.5 million settlement with the state of New Hampshire to end claims that the company's opioid marketing...To view the full article, register now.
Already a subscriber? Click here to view full article